Literature DB >> 19327960

Prognosis and 1-year mortality of intensive care unit patients with severe hepatic encephalopathy.

Jérôme Fichet1, Emmanuelle Mercier, Olivier Genée, Denis Garot, Annick Legras, Pierre-François Dequin, Dominique Perrotin.   

Abstract

PURPOSE: Data regarding outcome of patients with chronic liver disease with severe hepatic encephalopathy in intensive care unit are currently scarce.
METHODS: This study is a retrospective observational case series in a medical intensive care unit (ICU) in a university hospital from 1995 to 2005. Patients with hepatic encephalopathy (HE) (admitted with or developing) were identified. Clinical and laboratory parameters were analyzed to determinate predictors of ICU and 1-year mortality.
RESULTS: Seventy-one patients were included (53 male). Median Simplified Acute Physiology Score was 56 with Child-Pugh score 11 +/- 2. Seventy-six percent of patients were admitted with coma (Glasgow Coma Scale, 7.7 +/- 4). Eighty-two percent of patients required intubation, and 28% vasopressors. Thirty-five percent died during ICU stay. At 1 year, mortality was 54%. Univariate analysis identified arterial hypotension, mechanical ventilation, vasopressors at any time, acute renal failure, Simplified Acute Physiology Score, and sepsis associated with ICU mortality. In multivariate analysis, vasopressor use or acute renal failure was the main independent predictor of ICU death and 1-year mortality. Patients free of these risk factors, even requiring intubation, were identified as isolated HE, with lower mortality rates.
CONCLUSION: Predictors of outcome were similar to other groups of patients with liver disease admitted for other reasons. Intensive care unit mortality was lower than reported for other groups of patients with similar illness. Patients with severe HE admitted to ICU with no organ dysfunction other than mechanical ventilation had a better outcome and may require ICU admission.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19327960     DOI: 10.1016/j.jcrc.2009.01.008

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  34 in total

Review 1.  Management of covert hepatic encephalopathy.

Authors:  Abhijeet Waghray; Nisheet Waghray; Kevin Mullen
Journal:  J Clin Exp Hepatol       Date:  2014-04-01

2.  Predictors of Re-bleeding and Mortality Among Patients with Refractory Variceal Bleeding Undergoing Salvage Transjugular Intrahepatic Portosystemic Shunt (TIPS).

Authors:  Sergio Maimone; Francesca Saffioti; Roberto Filomia; Angela Alibrandi; Grazia Isgrò; Vincenza Calvaruso; Elias Xirouchakis; Gian Piero Guerrini; Andrew K Burroughs; Emmanuel Tsochatzis; David Patch
Journal:  Dig Dis Sci       Date:  2018-12-17       Impact factor: 3.199

3.  Postoperative resource utilization and survival among liver transplant recipients with Model for End-stage Liver Disease score ≥ 40: A retrospective cohort study.

Authors:  Filipe S Cardoso; Constantine J Karvellas; Norman M Kneteman; Glenda Meeberg; Pedro Fidalgo; Sean M Bagshaw
Journal:  Can J Gastroenterol Hepatol       Date:  2015-05

Review 4.  Acute-on-Chronic Liver Failure.

Authors:  Sumeet K Asrani; Douglas A Simonetto; Patrick S Kamath
Journal:  Clin Gastroenterol Hepatol       Date:  2015-07-15       Impact factor: 11.382

5.  Development and Validation of a Novel Model for Outcomes in Patients with Cirrhosis and Acute Variceal Bleeding.

Authors:  Gyanranjan Rout; Sanchit Sharma; Deepak Gunjan; Saurabh Kedia; Anoop Saraya; Baibaswata Nayak; Vishwajeet Singh; Ramesh Kumar
Journal:  Dig Dis Sci       Date:  2019-03-04       Impact factor: 3.199

Review 6.  Advances in cirrhosis: Optimizing the management of hepatic encephalopathy.

Authors:  Andy Liu; Ryan B Perumpail; Radhika Kumari; Zobair M Younossi; Robert J Wong; Aijaz Ahmed
Journal:  World J Hepatol       Date:  2015-12-18

Review 7.  Branched-chain amino acids for people with hepatic encephalopathy.

Authors:  Lise Lotte Gluud; Gitte Dam; Iñigo Les; Giulio Marchesini; Mette Borre; Niels Kristian Aagaard; Hendrik Vilstrup
Journal:  Cochrane Database Syst Rev       Date:  2017-05-18

8.  Amelioration of thioacetamide-induced hepatic encephalopathy in rats by low-dose gamma irradiation.

Authors:  Mona Abd El-Latif El-Ghazaly; Engy Refaat Rashed; Ghada Mahmoud Shafey; Hala Fahmy Zaki; Amina Salem Attia
Journal:  Environ Sci Pollut Res Int       Date:  2019-11-30       Impact factor: 4.223

Review 9.  Intensive Care Therapy for Patients with Advanced Liver Diseases.

Authors:  Antonios Katsounas; Ali Canbay
Journal:  Visc Med       Date:  2018-08-08

10.  Minimal Hepatic Encephalopathy and Biejia-Ruangan Are Associated with First Hospital Readmission in Nonalcoholic Cirrhosis Patients.

Authors:  Ting-Ting Jiang; Xiao-Li Liu; Yu-Yong Jiang; Xian-Bo Wang; Zhi-Yun Yang
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-07       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.